StockWatch
·
Pharmaceuticals
Quarterly Result2 Jul 2026, 09:30 pm

Dipna Pharmachem Declares FY26 Results, Approves Deviation Statement

AI Summary

Dipna Pharmachem Ltd announced its audited financial results for the quarter and year ended March 31, 2026. The company reported a net profit of ₹17.86 Lakhs for the quarter and ₹263.19 Lakhs for the year. The Board of Directors also approved the Statement of Deviations/Variations for the proceeds of a Preferential Issue - Convertible Warrants for the year ended March 31, 2026. The company has adopted IND AS for its financial reporting.

Key Highlights

  • FY26 Net Profit stands at ₹263.19 Lakhs.
  • Q4 FY26 Net Profit reported at ₹17.86 Lakhs.
  • Statement of Deviations/Variations approved.
  • Company adopted IND AS for financial reporting.
  • Board meeting held on July 2, 2026.